BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 19056351)

  • 1. Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography.
    Lee DS; Kim BM; Seol DW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):640-4. PubMed ID: 19056351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.
    Eglon MN; Duffy AM; O'Brien T; Strappe PM
    J Gene Med; 2009 Nov; 11(11):978-89. PubMed ID: 19670285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of adenoviral vectors using expanded bed chromatography.
    Peixoto C; Ferreira TB; Carrondo MJ; Cruz PE; Alves PM
    J Virol Methods; 2006 Mar; 132(1-2):121-6. PubMed ID: 16266756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards purification of adenoviral vectors based on membrane technology.
    Peixoto C; Ferreira TB; Sousa MF; Carrondo MJ; Alves PM
    Biotechnol Prog; 2008; 24(6):1290-6. PubMed ID: 19194943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaleable purification of adenovirus vectors.
    Konz JO; Pitts LR; Sagar SL
    Methods Mol Biol; 2008; 434():13-23. PubMed ID: 18470636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immobilized metal membrane affinity chromatography for purification of an immunoglobulin G1 monoclonal antibody.
    Serpa G; Augusto EF; Tamashiro WM; Ribeiro MB; Miranda EA; Bueno SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):259-68. PubMed ID: 15664358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles.
    Blanche F; Cameron B; Barbot A; Ferrero L; Guillemin T; Guyot S; Somarriba S; Bisch D
    Gene Ther; 2000 Jun; 7(12):1055-62. PubMed ID: 10871755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
    O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
    J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new scalable method for the purification of recombinant adenovirus vectors.
    Green AP; Huang JJ; Scott MO; Kierstead TD; Beaupré I; Gao GP; Wilson JM
    Hum Gene Ther; 2002 Nov; 13(16):1921-34. PubMed ID: 12427304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography.
    Qu G; Bahr-Davidson J; Prado J; Tai A; Cataniag F; McDonnell J; Zhou J; Hauck B; Luna J; Sommer JM; Smith P; Zhou S; Colosi P; High KA; Pierce GF; Wright JF
    J Virol Methods; 2007 Mar; 140(1-2):183-92. PubMed ID: 17196264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM; Kamen A; Garnier A
    Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
    Segura MM; Kamen A; Trudel P; Garnier A
    Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
    Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA.
    Konz JO; Lee AL; Lewis JA; Sagar SL
    Biotechnol Prog; 2005; 21(2):466-72. PubMed ID: 15801787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaleable purification process for gene therapy retroviral vectors.
    Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE
    J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC purification of adenoviral vectors.
    Eglon M; McGrath B; O'Brien T
    Methods Mol Biol; 2010; 594():395-408. PubMed ID: 20072933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock.
    Davidoff AM; Ng CY; Sleep S; Gray J; Azam S; Zhao Y; McIntosh JH; Karimipoor M; Nathwani AC
    J Virol Methods; 2004 Nov; 121(2):209-15. PubMed ID: 15381358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery.
    Croyle MA; Anderson DJ; Roessler BJ; Amidon GL
    Pharm Dev Technol; 1998 Aug; 3(3):365-72. PubMed ID: 9742557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.